Abstract:Research purpose: The low treatment effectiveness in major depressive disorder (MDD) may be caused by the subjectiveness in clinical examination and the lack of quantitative tests. Objective biomarkers derived from magnetic resonance imaging (MRI) may support clinical experts during decision-making. Numerous studies have attempted to identify such MRI-based biomarkers. However, the majority is uni-modal (based on a single MRI modality) and focus on either MDD diagnosis or outcome. Uncertainty remains regarding whether key features or classification models for diagnosis may also be used for outcome prediction. Therefore, we aim to find multi-modal predictors of both, MDD diagnosis and outcome. By addressing these research questions using the same dataset, we eliminate between-study confounding factors. Various structural (T1-weighted, T2-weighted, diffusion tensor imaging (DTI)) and functional (resting-state and task-based functional MRI) scans were acquired from 32 MDD and 31 healthy control (HC) subjects during the first visit at the investigational site (baseline). Depression severity was assessed at baseline and 6 months later. Features were extracted from the baseline MRI images with different modalities. Binary 6-months negative and positive outcome (NO; PO) classes were defined based on relative (to baseline) change in depression severity. Support vector machine models were employed to separate MDD from HC (diagnosis) and NO from PO subjects (outcome). Classification was performed through a uni-modal (features from a single MRI modality) and multi-modal (combination of features from different modalities) approach. Principal results: Our results show that DTI features yielded the highest uni-modal performance for diagnosis and outcome prediction: mean diffusivity (AUC (area under the curve) = 0.701) and the sum of streamline weights (AUC = 0.860), respectively. Multi-modal ensemble classifiers with T1-weighted, resting-state functional MRI and DTI features improved classification performance for both diagnosis and outcome (AUC = 0.746 and 0.932, respectively). Feature analyses revealed that the most important features were located in frontal, limbic and parietal areas. However, the modality or location of these features was different between diagnostic and prognostic models. Major conclusions: Our findings suggest that combining features from different MRI modalities predict MDD diagnosis and outcome with higher performance. Furthermore, we demonstrated that the most important features for MDD diagnosis were different and located in other brain regions than those for outcome. This longitudinal study contributes to the identification of objective biomarkers of MDD and its outcome. Follow-up studies may further evaluate the generalizability of our models in larger or multi-center cohorts.

Diagnostic Potential of Structural Neuroimaging for Depression from a Multi-Ethnic Community Sample.

Identifying Subgroups of Major Depressive Disorder Using Brain Structural Covariance Networks and Mapping of Associated Clinical and Cognitive Variables

An empirical analysis of structural neuroimaging profiles in a staging model of depression

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities

Structural alterations as a predictor of depression – a 7-Tesla MRI-based multidimensional approach

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Multi-modal MRI for objective diagnosis and outcome prediction in depression

Innovative Neuroimaging Biomarker Distinction of Major Depressive Disorder and Bipolar Disorder through Structural Connectome Analysis and Machine Learning Models

Diagnosis of Major Depressive Disorder Based on Individualized Brain Functional and Structural Connectivity

Multimodal fusion of structural and functional brain imaging in depression using linked independent component analysis

Functional and Structural Alterations As Diagnostic Imaging Markers for Depression in De Novo Parkinson’s Disease

Prognostic prediction of therapeutic response in depression using high-field MR imaging.

AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale

Capturing the Individual Deviations from Normative Models of Brain Structure for Depression Diagnosis and Treatment.

Distinguishing Bipolar and Major Depressive Disorders by Brain Structural Morphometry: A Pilot Study

Characterization of Major Depressive Disorder Using a Multiparametric Classification Approach Based on High Resolution Structural Images.

Translational Application of Neuroimaging in Major Depressive Disorder: a Review of Psychoradiological Studies

Brain structure alterations in depression: Psychoradiological evidence

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Multi-modal morphometric association study of subclinical depressive symptoms using voxel-based morphometry, cortical thickness, and diffusion tensor imaging (DTI)